MediWound to Host Analyst Day on its Innovative Product EscharEx® for Debridement of Chronic Wounds
MediWound Ltd. - Ordinary Shares (MDWD)
Last mediwound ltd. - ordinary shares earnings: 2/25 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.mediwound.com/press-releases
Company Research
Source: GlobeNewswire
YAVNE, Israel, July 16, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, will host an analyst day on its innovative product for chronic wounds on Monday, July 22nd at 12:00pm EDT in New York City. The meeting will feature a presentation by key opinion leader (KOL) John Lantis, MD, Mount Sinai West, St. Luke’s Roosevelt Hospitals, and the Icahn School of Medicine, who will discuss the current treatment landscape as well as the unmet medical need for treating patients with chronic wounds. Dr. Lantis will be available to answer questions at the conclusion of the event. MediWound’s management team will also provide a business status update and a clinical development plan update for EscharEx®. EscharEx is a biological drug containing a mixture of proteolytic enzymes being developed for debridement of chronic and other hard-to-heal wounds. It's an
Show less
Read more
Impact Snapshot
Event Time:
MDWD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDWD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDWD alerts
High impacting MediWound Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MDWD
News
- MediWound to Report Third Quarter 2024 Financial ResultsGlobeNewswire
- MediWound's (NASDAQ:MDWD) investors will be pleased with their stellar 125% return over the last year [Yahoo! Finance]Yahoo! Finance
- MediWound Ltd. (NASDAQ: MDWD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.MarketBeat
- MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg UlcersGlobeNewswire
- MediWound to Participate in the 2024 Maxim Healthcare Virtual SummitGlobeNewswire
MDWD
Earnings
- 8/14/24 - Miss
MDWD
Analyst Actions
- 10/11/24 - HC Wainwright
MDWD
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form 6-K
- 10/23/24 - Form SC
- MDWD's page on the SEC website